Review Article
Current and Emerging Cell Culture Manufacturing Technologies for Influenza Vaccines
| Technology | Company | Phase of development |
| Recombinant (VLP) | VLP (HA, NA, and M) insect cell | Novavax | Clinical trial phase 2 |
| Vectors | Adenovirus | Paxvax | Clinical trial phase 2 | Adenovirus | Vaxart | Clinical trial phase 1 |
| Cell-based LAIV | MDCK H5N1 | MedImmune | Preclinical | dNS1-Vero | Vivaldi Biosciences | Phase 1 | dNS1-Vero | AVIR Green Hills Biotech | Phase 2 |
|
|